Literature DB >> 27832051

Incidence of Zika Virus Disease by Age and Sex - Puerto Rico, November 1, 2015-October 20, 2016.

Matthew Lozier, Laura Adams, Mitchelle Flores Febo, Jomil Torres-Aponte, Melissa Bello-Pagan, Kyle R Ryff, Jorge Munoz-Jordan, Myriam Garcia, Aidsa Rivera, Jennifer S Read, Stephen H Waterman, Tyler M Sharp, Brenda Rivera-Garcia.   

Abstract

Zika virus is a flavivirus transmitted primarily by Aedes species mosquitoes; symptoms of infection include rash, arthralgia, fever, and conjunctivitis.*,† Zika virus infection during pregnancy can cause microcephaly and other serious brain anomalies (1), and in rare cases, Zika virus infection has been associated with Guillain-Barré syndrome (2) and severe thrombocytopenia (3). This report describes the incidence of reported symptomatic Zika virus disease in the U.S. territory of Puerto Rico by age and sex. During November 1, 2015-October 20, 2016, 62,500 suspected Zika virus disease cases were reported to the Puerto Rico Department of Health (PRDH); 29,345 (47%) were confirmed by reverse transcription-polymerase chain reaction (RT-PCR) testing, or were presumptively diagnosed based on serological testing. The highest incidence among confirmed or presumptive cases occurred among persons aged 20-29 years (1,150 cases per 100,000 residents). Among 28,219 (96.2%) nonpregnant patients with confirmed or presumptive Zika virus disease, incidence was higher among women (936 per 100,000 population) than men (576 per 100,000) for all age groups ≥20 years, and the majority (61%) of reported Zika virus disease cases occurred in females. Among suspected Zika virus disease cases in nonpregnant adults aged ≥40 years, the percentage that tested positive among females (52%) was higher than that among males (47%) (p<0.01). Reasons for the higher incidence of Zika virus disease among women aged ≥20 years are not known; serosurveys of persons living near confirmed Zika virus disease cases might help to elucidate these findings. Residents of and travelers to Puerto Rico should remove or cover standing water, practice mosquito abatement, employ mosquito bite avoidance behaviors, take precautions to reduce the risk for sexual transmission, and seek medical care for any acute illness with rash or fever.

Entities:  

Mesh:

Year:  2016        PMID: 27832051     DOI: 10.15585/mmwr.mm6544a4

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  32 in total

1.  Clinical Features of Guillain-Barré Syndrome With vs Without Zika Virus Infection, Puerto Rico, 2016.

Authors:  Emilio Dirlikov; Chelsea G Major; Nicole A Medina; Roberta Lugo-Robles; Desiree Matos; Jorge L Muñoz-Jordan; Candimar Colon-Sanchez; Myriam Garcia; Marangely Olivero-Segarra; Graciela Malave; Gloria M Rodríguez-Vega; Dana L Thomas; Stephen H Waterman; James J Sejvar; Carlos A Luciano; Tyler M Sharp; Brenda Rivera-García
Journal:  JAMA Neurol       Date:  2018-09-01       Impact factor: 18.302

Review 2.  Mosquito-borne and sexual transmission of Zika virus: Recent developments and future directions.

Authors:  Tereza Magalhaes; Brian D Foy; Ernesto T A Marques; Gregory D Ebel; James Weger-Lucarelli
Journal:  Virus Res       Date:  2017-07-11       Impact factor: 3.303

3.  Medical School Hotline: Pacific Center for Emerging Infectious Diseases Research.

Authors:  Richard Yanagihara; Vivek R Nerurkar; George Hui; Gwen A Jacobs
Journal:  Hawaii J Med Public Health       Date:  2017-01

4.  Zika Virus in Israeli Travelers: Emergence of Asia as a Major Source of Infection.

Authors:  Eyal Meltzer; Yaniv Lustig; Eli Schwartz
Journal:  Am J Trop Med Hyg       Date:  2019-01       Impact factor: 2.345

5.  Tryptophan Trimers and Tetramers Inhibit Dengue and Zika Virus Replication by Interfering with Viral Attachment Processes.

Authors:  Antonios Fikatas; Peter Vervaeke; Belén Martínez-Gualda; Olaia Martí-Marí; Sam Noppen; Eef Meyen; María-José Camarasa; Ana San-Félix; Christophe Pannecouque; Dominique Schols
Journal:  Antimicrob Agents Chemother       Date:  2020-02-21       Impact factor: 5.191

Review 6.  Zika in the Americas, year 2: What have we learned? What gaps remain? A report from the Global Virus Network.

Authors:  Matthew T Aliota; Leda Bassit; Shelton S Bradrick; Bryan Cox; Mariano A Garcia-Blanco; Christina Gavegnano; Thomas C Friedrich; Thaddeus G Golos; Diane E Griffin; Andrew D Haddow; Esper G Kallas; Uriel Kitron; Marc Lecuit; Diogo M Magnani; Caroline Marrs; Natalia Mercer; Edward McSweegan; Lisa F P Ng; David H O'Connor; Jorge E Osorio; Guilherme S Ribeiro; Michael Ricciardi; Shannan L Rossi; George Saade; Raymond F Schinazi; Geraldine O Schott-Lerner; Chao Shan; Pei-Yong Shi; David I Watkins; Nikos Vasilakis; Scott C Weaver
Journal:  Antiviral Res       Date:  2017-06-06       Impact factor: 5.970

7.  Long-term circulation of Zika virus in Thailand: an observational study.

Authors:  Kriangsak Ruchusatsawat; Pattara Wongjaroen; Arisara Posanacharoen; Isabel Rodriguez-Barraquer; Somchai Sangkitporn; Derek A T Cummings; Henrik Salje
Journal:  Lancet Infect Dis       Date:  2019-02-27       Impact factor: 25.071

8.  The Role of Public-Private Partnerships to Increase Access to Contraception in an Emergency Response Setting: The Zika Contraception Access Network Program.

Authors:  Lisa Romero; Zipatly V Mendoza; Laura Croft; Reema Bhakta; Turquoise Sidibe; Nabal Bracero; Claritsa Malave; Alicia Suarez; Linette Sanchez; Darielys Cordero; Eva Lathrop; Judith Monroe
Journal:  J Womens Health (Larchmt)       Date:  2020-11       Impact factor: 2.681

9.  Program Fidelity and Patient Satisfaction among Women Served by the Zika Contraception Access Network Program in Puerto Rico.

Authors:  Lauren B Zapata; Lisa Romero; Maria I Rivera; Stephanie K Rivera-Soto; Stacey Hurst; Zipatly V Mendoza; Heather B Clayton; Nabal Bracero; Maura K Whiteman; Eva Lathrop
Journal:  Womens Health Issues       Date:  2020-05-04

10.  A Structure-Informed Atlas of Human-Virus Interactions.

Authors:  Gorka Lasso; Sandra V Mayer; Evandro R Winkelmann; Tim Chu; Oliver Elliot; Juan Angel Patino-Galindo; Kernyu Park; Raul Rabadan; Barry Honig; Sagi D Shapira
Journal:  Cell       Date:  2019-08-29       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.